Published in Int J Tuberc Lung Dis on October 01, 2001
Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study. Lancet (2007) 3.65
Challenges in estimating the total burden of drug-resistant tuberculosis. Am J Respir Crit Care Med (2008) 2.33
Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda. Clin Infect Dis (2008) 2.26
Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis. Clin Infect Dis (2009) 2.25
Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method. Antimicrob Agents Chemother (2003) 1.93
Prevalence and risk factors for multidrug-resistant tuberculosis in the Republic of Georgia: a population-based study. Int J Tuberc Lung Dis (2009) 1.79
Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community. PLoS One (2010) 1.57
Multidrug- and extensively drug-resistant tuberculosis, Germany. Emerg Infect Dis (2008) 1.43
Increasing antituberculosis drug resistance in the United Kingdom: analysis of National Surveillance Data. BMJ (2008) 1.36
Drug-resistant tuberculosis in Shanghai, China, 2000-2006: prevalence, trends and risk factors. Int J Tuberc Lung Dis (2009) 1.31
Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain. Eur J Clin Microbiol Infect Dis (2008) 1.29
Drug resistance rates of Mycobacterium tuberculosis at a private referral center in Korea. J Korean Med Sci (2007) 1.25
Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum-positive pulmonary tuberculosis. Indian J Med Res (2011) 1.18
Tuberculosis: a global health problem. J Health Popul Nutr (2010) 1.17
High prevalence of multidrug-resistant tuberculosis in Georgia. Int J Infect Dis (2008) 1.13
Association between HIV/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysis. PLoS One (2014) 1.12
Factors associated with low cure rate of tuberculosis in remote poor areas of Shaanxi Province, China: a case control study. BMC Public Health (2010) 1.12
Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum. PLoS Pathog (2012) 1.06
Tuberculosis drug resistance and HIV infection, the Netherlands. Emerg Infect Dis (2007) 1.04
Clinical prediction rule for stratifying risk of pulmonary multidrug-resistant tuberculosis. PLoS One (2010) 1.03
Spatial epidemiology and spatial ecology study of worldwide drug-resistant tuberculosis. Int J Health Geogr (2011) 1.01
A global health elective course in a PharmD curriculum. Am J Pharm Educ (2014) 0.99
Development of multidrug resistant tuberculosis in Bangladesh: a case-control study on risk factors. PLoS One (2014) 0.98
Direct detection of rifampin-resistant mycobacterium tuberculosis in respiratory specimens by PCR-DNA sequencing. J Clin Microbiol (2004) 0.93
Evaluation of amplified rDNA restriction analysis (ARDRA) for the identification of cultured mycobacteria in a diagnostic laboratory. BMC Microbiol (2002) 0.92
Multidrug-resistant tuberculosis and the need for biosocial perspectives. Int J Tuberc Lung Dis (2001) 0.90
Extensively drug-resistant tuberculosis, Burkina Faso. Emerg Infect Dis (2010) 0.89
MDR-TB screening in a setting with molecular diagnostic techniques: who got tested, who didn't and why? Public Health Action (2015) 0.87
Drug resistance of Mycobacterium tuberculosis in Malawi: a cross-sectional survey. Bull World Health Organ (2014) 0.87
Epidemiology and genetic diversity of multidrug-resistant tuberculosis in East Africa. Tuberculosis (Edinb) (2013) 0.86
Tuberculosis diagnosed in a rural setting in Angola. Accuracy of follow-up sputum smears to predict outcome. Pathog Glob Health (2013) 0.84
Multidrug-resistant Mycobacterium tuberculosis, Bangui, Central African Republic. Emerg Infect Dis (2006) 0.82
Assessing the effect of decentralisation of laboratory diagnosis for drug-resistant tuberculosis in Kenya. Int J Tuberc Lung Dis (2015) 0.81
Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis. BMC Pulm Med (2016) 0.81
Association between Multidrug-Resistant Tuberculosis and Risk Factors in China: Applying Partial Least Squares Path Modeling. PLoS One (2015) 0.78
Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin- Mono-Resistant Pulmonary Tuberculosis in Lima, Peru. PLoS One (2016) 0.78
Multidrug and extensively drug-resistant tuberculosis from a general practice perspective. Infect Drug Resist (2010) 0.77
Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe. Int J Tuberc Lung Dis (2016) 0.77
Rationing tests for drug-resistant tuberculosis - who are we prepared to miss? BMC Med (2016) 0.75
Factors related to previous tuberculosis treatment of patients with multidrug-resistant tuberculosis in Bangladesh. BMJ Open (2015) 0.75
Increasing access to the MDR-TB surveillance programme through a collaborative model in western Kenya. Trop Med Int Health (2011) 0.75
Epidemiology of Drug-resistant Tuberculosis in a Tertiary Care Center in Oman, 2006-2015. Oman Med J (2017) 0.75
The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat (1992) 29.45
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA (1999) 27.82
Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med (1998) 10.78
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J (2011) 8.96
Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA (2000) 8.42
Genetic mapping in Bacillus subtilis. J Mol Biol (1967) 7.61
Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ (1994) 6.11
Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med (2001) 6.05
Plastic mattresses and sudden infant death syndrome. Lancet (1995) 5.59
Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg Infect Dis (1998) 5.51
Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). J Clin Microbiol (1999) 5.28
Gene conservation in Bacillus species. I. Conserved genetic and nucleic acid base sequence homologies. Proc Natl Acad Sci U S A (1965) 4.81
The Mycobacterium tuberculosis ECF sigma factor sigmaE: role in global gene expression and survival in macrophages. Mol Microbiol (2001) 4.60
Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis (2005) 4.57
Ribosomal RNA synthesis and processing in a particulate site in the HeLa cell nucleus. Science (1966) 4.43
Differential expression of 10 sigma factor genes in Mycobacterium tuberculosis. Mol Microbiol (1999) 4.27
Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. Clin Infect Dis (1997) 4.02
HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tuber Lung Dis (1992) 3.95
Bacillus sporulation gene spo0H codes for sigma 30 (sigma H). J Bacteriol (1988) 3.88
Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate. J Clin Oncol (1998) 3.69
125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic? Eur Respir J (2007) 3.67
[Occurrence of tertian malaria in a male patient who has never been abroad]. Korean J Parasitol (1994) 3.59
Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea. Aliment Pharmacol Ther (2011) 3.56
Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res (1999) 3.40
Costs and benefits of cervical screening. I. The costs of the cervical screening programme. Cytopathology (1996) 3.25
Public health. Responding to market failures in tuberculosis control. Science (2001) 3.12
Chromosomal location of DNA base sequences complementary to transfer RNA and to 5 s, 16 s and 23 s ribosomal RNA in Bacillus subtilis. J Mol Biol (1968) 3.01
A new dynamin-like protein, ADL6, is involved in trafficking from the trans-Golgi network to the central vacuole in Arabidopsis. Plant Cell (2001) 3.01
The seventh nationwide tuberculosis prevalence survey in Korea, 1995. Int J Tuberc Lung Dis (1998) 2.90
Trend of anti-tuberculosis drug resistance in Korea, 1994-2004. Int J Tuberc Lung Dis (2007) 2.85
Nonradioactive method to study genetic profiles of natural bacterial communities by PCR-single-strand-conformation polymorphism. Appl Environ Microbiol (1996) 2.78
SinI modulates the activity of SinR, a developmental switch protein of Bacillus subtilis, by protein-protein interaction. Genes Dev (1993) 2.77
Genetic enhancement of inflammatory pain by forebrain NR2B overexpression. Nat Neurosci (2001) 2.72
Increased risk of Mycobacterium tuberculosis infection related to the occupational exposures of health care workers in Chiang Rai, Thailand. Int J Tuberc Lung Dis (1999) 2.68
Survey of neonatal screening for primary hypothyroidism in England, Wales, and Northern Ireland 1982-4. Br Med J (Clin Res Ed) (1988) 2.65
Species identification of mycobacteria by PCR-restriction fragment length polymorphism of the rpoB gene. J Clin Microbiol (2000) 2.62
Characterization of a cloned Bacillus subtilis gene that inhibits sporulation in multiple copies. J Bacteriol (1986) 2.59
Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol Microbiol (2000) 2.59
Transformation and transduction in Bacillus subtilis: evidence for separate modes of recombinant formation. J Mol Biol (1969) 2.56
Measuring tuberculosis burden, trends, and the impact of control programmes. Lancet Infect Dis (2008) 2.55
Bacillus subtilis early sporulation genes kinA, spo0F, and spo0A are transcribed by the RNA polymerase containing sigma H. J Bacteriol (1992) 2.50
Clinical and operational value of the extensively drug-resistant tuberculosis definition. Eur Respir J (2007) 2.46
Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor. J Exp Med (2000) 2.45
A Bacillus subtilis regulatory gene product for genetic competence and sporulation resembles sensor protein members of the bacterial two-component signal-transduction systems. Genes Dev (1990) 2.44
Laparoscopic resection of gastric diverticulum. J Laparoendosc Adv Surg Tech A (1999) 2.39
The secreted antigens of Mycobacterium tuberculosis and their relationship to those recognized by the available antibodies. J Gen Microbiol (1988) 2.38
Non-CPAP therapies in obstructive sleep apnoea. Eur Respir J (2011) 2.36
The Mycobacterium tuberculosis IdeR is a dual functional regulator that controls transcription of genes involved in iron acquisition, iron storage and survival in macrophages. Mol Microbiol (2001) 2.34
Retracted Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue. Nature (2000) 2.31
Trafficking of phosphatidylinositol 3-phosphate from the trans-Golgi network to the lumen of the central vacuole in plant cells. Plant Cell (2001) 2.28
Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res (2000) 2.22
Regulation of spo0H, a gene coding for the Bacillus subtilis sigma H factor. J Bacteriol (1991) 2.19
Electron microscopic studies of detergent-treated HeLa cell nuclei. J Mol Biol (1966) 2.19
Bacillus subtilis spo0H gene. J Bacteriol (1984) 2.18
Galactomannan antigenemia and antigenuria in aspergillosis: studies in patients and experimentally infected rabbits. J Infect Dis (1987) 2.18
A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motif. Nat Cell Biol (2000) 2.17
Bleeding Dieulafoy's lesions and the choice of endoscopic method: comparing the hemostatic efficacy of mechanical and injection methods. Gastrointest Endosc (2000) 2.16
Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet (2000) 2.15
The Arthritis and Rheumatism Council's National Repository of Family Material: pedigrees from the first 100 rheumatoid arthritis families containing affected sibling pairs. Br J Rheumatol (1994) 2.14
Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res (1994) 2.13
Assessment of pre-operative investigations of thyroglossal cysts. J R Coll Surg Edinb (1996) 2.13
Cost-effectiveness analysis of antiemetic therapy for ambulatory surgery. J Clin Anesth (1995) 2.09
Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA (1995) 2.08
Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice. Am Rev Respir Dis (1993) 2.07
Pacifier use and sudden infant death syndrome: results from the CESDI/SUDI case control study. CESDI SUDI Research Team. Arch Dis Child (1999) 2.07
Tuberculosis control in Europe and international migration. Eur Respir J (1994) 2.07
Spastic paraparesis after anaesthesia. Lancet (1999) 2.06
Restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolated from countries in the western pacific region. J Clin Microbiol (2000) 2.05
Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut (2001) 2.05
Gene conservation in Bacillus species. II. The location of genes concerned with the synthesis of ribosomal components and soluble RNA. Proc Natl Acad Sci U S A (1965) 2.04
Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa. Antimicrob Agents Chemother (1997) 1.99
Alcohol and driving: is the 0.05% blood alcohol concentration limit justified? Drug Alcohol Rev (1991) 1.98
Genetics and physiology of the rel system of Bacillus subtilis. Mol Gen Genet (1980) 1.95
Regulation of spo0H, an early sporulation gene in bacilli. J Bacteriol (1987) 1.94
Intracranial stenting of severe symptomatic intracranial stenosis: results of 100 consecutive patients. AJNR Am J Neuroradiol (2008) 1.93
Characterization of an iron-dependent regulatory protein (IdeR) of Mycobacterium tuberculosis as a functional homolog of the diphtheria toxin repressor (DtxR) from Corynebacterium diphtheriae. Infect Immun (1995) 1.92
Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues. Int J Tuberc Lung Dis (2009) 1.92
Genetic mapping of antibiotic resistance in markers Bacillus subtilis. Proc Natl Acad Sci U S A (1970) 1.92
Progress in global tuberculosis control 1995-1996, with emphasis on 22 high-incidence countries. Global Monitoring and Surveillance Project. Int J Tuberc Lung Dis (1999) 1.90
Inhalation induction with sevoflurane: a double-blind comparison with propofol. Br J Anaesth (1997) 1.90
Mutations in the rpoB gene of Mycobacterium tuberculosis that interfere with PCR-single-strand conformation polymorphism analysis for rifampin susceptibility testing. J Clin Microbiol (1997) 1.89
Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta. Proc Natl Acad Sci U S A (1994) 1.87
Effects of insertion conditions on tissue strain and vascular damage during neuroprosthetic device insertion. J Neural Eng (2006) 1.86
A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res (1995) 1.86
Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy. Int J Tuberc Lung Dis (2002) 1.86
Risk factors associated with default from multidrug-resistant tuberculosis treatment, South Africa, 1999-2001. Int J Tuberc Lung Dis (2006) 1.86
Quantitative studies on the dispersal of skin bacteria into the air. J Med Microbiol (1976) 1.85
The regulation of AMP-activated protein kinase by H(2)O(2). Biochem Biophys Res Commun (2001) 1.84
The Bacillus subtilis sin gene, a regulator of alternate developmental processes, codes for a DNA-binding protein. J Bacteriol (1991) 1.84
Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana. Int J Tuberc Lung Dis (1999) 1.82
Identification of motifs for cell adhesion within the repeated domains of transforming growth factor-beta-induced gene, betaig-h3. J Biol Chem (2000) 1.82